Imunon, Inc. (IMNN)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 10, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Imunon, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company and its management of their responsibility for th… | Read Filing EDGAR |
| Aug. 13, 2025 | CORRESP | Concern from SEC | Moderate | Imunon, Inc. has submitted a response to the SEC's comment letter regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the company'… | Read Filing EDGAR |
| Aug. 4, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Imunon, Inc.'s Form 10-K for the fiscal year ended December 31, 2024, and has issued comments requiring clarification on intellectual property disclosures. Sp… | Read Filing EDGAR |
| Jun. 11, 2025 | CORRESP | Neutral/Informational | Moderate | Imunon, Inc. has submitted a request to the SEC to expedite the effectiveness of their Registration Statement on Form S-1, aiming for it to become effective by June 13, 2025. The … | Read Filing EDGAR |
| Jun. 5, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Imunon, Inc. that it will not review the company's registration statement on Form S-1, filed on May 30, 2025. The letter emphasizes the company's respo… | Read Filing EDGAR |
| May. 30, 2025 | CORRESP | Neutral/Informational | Low | Imunon, Inc. has submitted a Registration Statement on Form S-1 for a secondary offering of shares by certain stockholders. The correspondence is directed to the SEC, requesting f… | Read Filing EDGAR |